Journal of Clinical Endocrinology & Metabolism, Vol 62, 1027-1036, Copyright © 1986 by Endocrine Society

ARTICLES

Plasma levels and cardiovascular, endocrine, and excretory effects of atrial natriuretic peptide during different sodium intakes in man

P Weidmann, B Hellmueller, DE Uehlinger, RE Lang, MP Gnaedinger, L Hasler, S Shaw and C Bachmann

Endogenous plasma concentrations of human atrial natriuretic peptide (alpha hANP) as well as effects of synthetic alpha hANP on some cardiovascular, endocrine, and renal excretory parameters were investigated in 10 normal subjects during sodium (Na+) intakes of 17, 140, and 310 mmol/day, respectively. Plasma hANP was slightly but not significantly higher after 5 days of normal or high sodium intake than after 5 days of low sodium intake [54 +/- 13, 46 +/- 8, and 37 +/- 5 (mean +/- SEM) pg/ml, respectively]. alpha hANP infused at 0.1 microgram/kg X min during all Na+ intakes produced a similar fall in diastolic blood pressure (P less than 0.001) and rise in heart rate (P less than 0.001), a comparable percent increase in plasma norepinephrine (P less than 0.001), and a reduction in plasma cortisol and aldosterone (P less than 0.01-0.001) despite raised renin activity (P less than 0.05-0.001) and unchanged plasma electrolytes. alpha hANP- induced plasma volume contraction, diuresis, and natriuresis were greater during high than low Na+ intake (P less than 0.01-0.001). Therefore, in normal man different Na+ intakes are accompanied by marked modifications in renal excretory responsiveness to alpha hANP. Regardless of sodium intake, alpha hANP can promote BP reduction and hemoconcentration, elicit reflex (?) sympathetic activation, and depress basal circulating aldosterone and cortisol levels in the face of an activated renin system.

This article has been cited by other articles:

				M. Schmitt, A. Qasem, C. McEniery, I. B. Wilkinson, V. Tatarinoff, K. Noble, J. Klemes, N. Payne, M. P. Frenneaux, J. Cockcroft, et al. Role of natriuretic peptides in regulation of conduit artery distensibility Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1167 - H1171. [Abstract] [Full Text] [PDF]

				L. G. MELO, M. E. STEINHELPER, S. C. PANG, Y. TSE, and U. ACKERMANN ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models Physiol Genomics, June 29, 2000; 3(1): 45 - 58. [Abstract] [Full Text] [PDF]

				L. G. Melo, A. T. Veress, C. K. Chong, U. Ackermann, and H. Sonnenberg Salt-sensitive hypertension in ANP knockout mice is prevented by AT1 receptor antagonist losartan Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1999; 277(3): R624 - R630. [Abstract] [Full Text] [PDF]

				A. Jansson and K. Dahlborn Effects of feeding frequency and voluntary salt intake on fluid and electrolyte regulation in athletic horses J Appl Physiol, May 1, 1999; 86(5): 1610 - 1616. [Abstract] [Full Text] [PDF]

				L. G. Melo, A. T. Veress, C. K. Chong, S. C. Pang, T. G. Flynn, and H. Sonnenberg Salt-sensitive hypertension in ANP knockout mice: potential role of abnormal plasma renin activity Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1998; 274(1): R255 - R261. [Abstract] [Full Text] [PDF]

				R. Gasser, O. Luha, J. Dusleag, B. Eber, R. Rotman, W. Klein, and G.R. Fueger Observations on Plasma ANP Levels During Short-Term Transient Myocardial Ischemia Produced by PTCA in Patients with LAD Stenosis Angiology, April 1, 1993; 44(4): 278 - 288. [Abstract] [PDF]